5 Companies Helping to Fight the After-Thanksgiving Day Bulge

D. Sharon Pruitt, Source: Flickr.

There a few holidays quite like Thanksgiving. I mean when else do we regularly get a day off toward the middle of the work week, surround ourselves with family and friends, and gorge ourselves with a dozen different types of food until our pants no longer fit? And for me, as a sports lover, I get to watch my Detroit Lions play, which has become a Thanksgiving Day tradition.

But Thanksgiving also has its negative connotation for being the holiday, or the start of the holiday season, that tends to pack on unwanted pounds for millions of Americans. It's no surprise that New Year's resolutions commonly entail losing the weight put on during the roughly five- or six-week holiday season, which begins on Thanksgiving.

With 35.7% of the nation considered obese already according to the Centers for Disease Control and Prevention, two-thirds of the nation considered overweight or obese according to standard Body Mass Index calculations, and the obesity officially classified as a disease by the American Medical Association, obesity awareness is growing right along with our waistlines. Thankfully, the number of companies creating product lines, services, or drugs to help us battle the bulge this holiday season is also increasing.

Here are five companies that could help us battle the bulge this holiday season.

Whole Foods Market (NASDAQ: WFM  )
Staying in shape this holiday season starts with eating more nutritious foods. That doesn't mean we can't indulge in that slice of pumpkin pie with whipped cream or add a little extra gravy to our mashed potatoes, but it does mean a growing focus on locally growing and organic products, especially meats, this season.

Make no mistake about it, Whole Foods isn't going to win any awards for being the low-price leader in any categories, but the assumption from consumers entering its stores is that they'll find a far better organic and locally grown selection of produce and meats than they will at any other major chain store. This lends Whole Foods some incredible pricing power and a very stable customer base, and it also sets up the expectation from the consumer that they're getting better quality food for that premium price.

Walgreen (NASDAQ: WBA  )
After eating the right foods, you might assume that a nutrition plan-based company or gym chain was up next, but you'll find none of that from me as exercise is assumed and consumer loyalty to nutritional plans is often horrendously low.

Instead, I would point to a drugstore like Walgreen, which is essentially a one-stop shop for health advice. In addition to doling out pharmaceutical products that can help people lose weight, Walgreen has also been one of the primary supporters of Obamacare. By helping to promote this new health reform law, the thinking would be that more people being insured would drive preventative doctors' visits, and would ultimately help curb some of the factors that lead to obesity, such as high cholesterol and diabetes.

Arena Pharmaceuticals (NASDAQ: ARNA  ) and VIVUS (NASDAQ: VVUS  )
When it comes to a pharmacological solution to trimming the fat, nothing can surpass the only two FDA-approved weight control management drugs, Belviq from Arena and Qsymia from VIVUS.

Now, understand that these drugs are prescribed in cases where there are chronic weight management issues, not just a pair of tight pants after a big meal. However, with no anti-obesity drugs approved in more than a decade and suddenly two reaching pharmacy shelves within the past year and change, the hope for slimming waistlines is high.

As it stands now both Belviq and Qsymia offer their own unique advantages. Qsymia, for example, delivered a higher percentage of weight-loss in trials, which you would think might give it a natural advantage over Belviq. However, Belviq's safety profile is preferred by physicians, and it also has a global marketing partner in Eisai compared to VIVUS, which is marketing Qsymia on its own. Neither drug has really lived up to its potential yet, but the reachable market for each drug is certainly big enough to accommodate both therapies.

Zeltiq Aesthetics (NASDAQ: ZLTQ  )
Last, but certainly not least, we have Zeltiq Aesthetics, which utilizes its proprietary medical devices for the selective reduction of fat in patients. Understandably, we're not talking about a pharmacological solution here or even a long-term one necessarily. This is more of an aesthetic solution in cases where diet and exercise aren't meeting the patients' goal, but it should be noted that people will pay top dollar to look healthier and thinner, so Zeltiq's target audience is actually very large.

Zeltiq's primary product is its CoolSculpting System, which is used to freeze fat cells under the skin. The product is designed not to harm healthy cells and allows frozen fat cells to die off below the skin and be removed from the body naturally over time. This lack of surgery creates no downtime for the patient and is about as pain-free as it gets!

It's pretty evident that demand in Zeltiq's CoolSculpting device is increasing dramatically because in just the past two quarters, it's doubled its full-year sales growth projections twice, first from 10% to 20% and more recently from 20% to 40%. It's an under-the-radar fat-busting name you should definitely know moving forward.

Curious about how Obamacare will affect your health-care options? Let us help!
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." But don't hesitate; because it's not often that we release a FREE guide containing this much information and money-making advice. Please click here to access your free copy.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 29, 2013, at 5:12 PM, prginww wrote:

    BELVIQ SCRIPS continue to rise nicely week after week. When DTC on tv starts in December look for huge stock gains. AND with those 65 MILLION SHORT SHARES this could be very very sweet.

    and lets not forget the partnerships for the entire world.


Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2745149, ~/Articles/ArticleHandler.aspx, 9/27/2016 8:22:11 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 11 hours ago Sponsored by:
DOW 18,094.83 -166.62 -0.91%
S&P 500 2,146.10 -18.59 -0.86%
NASD 5,257.49 -48.26 -0.91%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 4:00 PM
ARNA $1.73 Down -0.01 -0.57%
Arena Pharmaceutic… CAPS Rating: ***
VVUS $1.24 Up +0.11 +9.73%
VIVUS CAPS Rating: **
WBA $80.68 Down -1.37 -1.67%
Walgreens Boots Al… CAPS Rating: ****
WFM $28.65 Up +0.13 +0.46%
Whole Foods Market CAPS Rating: ****
ZLTQ $39.76 Down -0.48 -1.19%
Zeltiq Aesthetics CAPS Rating: **